Vicarious Surgical Inc. (RBOT)
NYSE: RBOT · Real-Time Price · USD
11.49
+1.20 (11.66%)
Nov 22, 2024, 4:00 PM EST - Market closed

Vicarious Surgical Income Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTM FY 2023 FY 2022 FY 2021 FY 2020 FY 2019
Period Ending
Sep '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19
Selling, General & Admin
26.9633.0936.1816.163.192.3
Research & Development
39.4346.8543.922.069.87.48
Operating Expenses
66.3979.9480.0838.2212.999.78
Operating Income
-66.39-79.94-80.08-38.22-12.99-9.78
Interest Expense
-0.02-0.03-0.2-0.09-0-0
Interest & Investment Income
3.664.431.440.020.110.47
Other Non Operating Income (Expenses)
1.075.19843.09--
EBT Excluding Unusual Items
-61.68-70.345.16-35.21-12.88-9.31
Merger & Restructuring Charges
-0.73-0.73----
Pretax Income
-62.41-71.075.16-35.21-12.88-9.31
Net Income
-62.41-71.075.16-35.21-12.88-9.31
Net Income to Common
-62.41-71.075.16-35.21-12.88-9.31
Shares Outstanding (Basic)
654330
Shares Outstanding (Diluted)
654330
Shares Change (YoY)
32.36%14.49%31.89%22.80%1501.50%-
EPS (Basic)
-10.63-14.601.27-10.92-4.91-56.83
EPS (Diluted)
-10.71-14.701.20-10.92-4.91-56.83
Free Cash Flow
--63.98-66.56-34.59-12.16-8.96
Free Cash Flow Per Share
--13.14-15.66-10.73-4.63-54.66
EBITDA
-64.25-78.08-78.97-37.91-12.83-9.68
D&A For EBITDA
2.141.851.110.320.160.1
EBIT
-66.39-79.94-80.08-38.22-12.99-9.78
Source: S&P Capital IQ. Standard template. Financial Sources.